Track topics on Twitter Track topics that are important to you
Pharmacyclics to supply ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), for a Phase 1b/2 trial
Pharmacyclics quietly released a statement on its website last Friday morning saying “we have received feedback” and will not yank the older pill.
PolarityTE, Inc. Announces the Addition of Ramses Erdtmann, Managing Partner at Point Sur Investors and Former Executive at Pharmacyclics, and David Seaburg, Managing Director at Cowen and CNBC Contributor, to the Board of Directors
SALT LAKE CITY, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patien...
The co-marketers of Imbruvica® (ibrutinib), AbbVie and Janssen (Johnson & Johnson), said today that the FDA has approved their drug in combination with the Genentech/Biogen co-marketed Rituxa...
CASI Pharmaceuticals Inc. (CASI) gained 21.81% on Tuesday, following a $50 million private placement. The financing was led by ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan...
The FDA granted priority review status to a supplemental new drug application for the combination use of Pharmacyclics and Ja -More-
Oncology firm CASI Pharmaceuticals Inc. entered into definitive agreements with investors (including ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan, former chairman and CEO ...
SummaryPharmacyclics Inc Pharmacyclics, a whollyowned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company'...
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune-mediated diseases and cancer. Our mi...
Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy andchemotherapy of cancer, and to enable or improve the photodynamic therapy of certai...
We have published hundreds of Pharmacyclics, Inc. news stories on BioPortfolio along with dozens of Pharmacyclics, Inc. Clinical Trials and PubMed Articles about Pharmacyclics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmacyclics, Inc. Companies in our database. You can also find out about relevant Pharmacyclics, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...